As AI becomes embedded across pharmacovigilance, the skills required of safety scientists are rapidly evolving. This article examines the shifting balance between human expertise and AI-enabled tools, outlining the competencies, training pathways, and cultural changes needed to prepare tomorrow’s hybrid PV workforce.
HEOR is taking on a broader role within modern CROs. In this podcast conversation hosted by HealthEconomics.com, UBC's Aaron Berger and Dr. Mir Sohail Fazeli discuss how integrated evidence delivery, strong methodology, and real‑world context are shaping the next generation of evidence strategies.
The history of depression treatment reflects a centuries-old tension between mind and body—and how we conceptualize the condition has always shaped how we treat it. Today, with up to 30% of patients classified as treatment-resistant, psychedelic-assisted therapies are attracting serious scientific and regulatory attention. But emerging evidence suggests that the therapeutic context surrounding these treatments—relationships, setting, and social environment—may matter as much as the compounds themselves.
In the realm of pharmaceuticals, regulatory compliance is paramount to ensure patient safety. With the complex environment of safety reporting, several vendors may be involved at global and local levels for performing submission activities to health authorities, ethics committees and investigators. Director of UBC Global Case Processing, Myrto Ioannidi and UBC Team Manager, Esther Aparicio review […]
Bekki Bracken Brown serves as the President and CEO of UBC, guiding the company’s mission and values, including the improvement of access for patients to receive better outcomes. She oversees all aspects of UBC, such as operations, business growth strategy, sales and marketing, and acquisition support.
With over 20 years of industry experience, Ms. Brown brings knowledge from a successful career in senior management from her tenure at Quintiles, INC Research, and, most recently, with Syneos Health. She’s been a member of the North Carolina BIO Board of Directors since 2019. She is also a member of the Healthcare Businesswomen’s Association — Southeast Chapter and CHIEF, an organization that supports women executive leaders. Ms. Brown earned her bachelor’s degree at Duke University.